Related references
Note: Only part of the references are listed.Matrine attenuates pathological cardiac fibrosis via RPS5/p38 in mice
Xin Zhang et al.
ACTA PHARMACOLOGICA SINICA (2021)
Fibronectin type III domain-containing 5 in cardiovascular and metabolic diseases: a promising biomarker and therapeutic target
Xin Zhang et al.
ACTA PHARMACOLOGICA SINICA (2021)
Endothelial ERG alleviates cardiac fibrosis via blocking endothelin-1-dependent paracrine mechanism
Xin Zhang et al.
CELL BIOLOGY AND TOXICOLOGY (2021)
FNDC5 alleviates oxidative stress and cardiomyocyte apoptosis in doxorubicin-induced cardiotoxicity via activating AKT
Xin Zhang et al.
CELL DEATH AND DIFFERENTIATION (2020)
Established and emerging therapeutic uses of PDE type 5 inhibitors in cardiovascular disease
Nikolaos Tzoumas et al.
BRITISH JOURNAL OF PHARMACOLOGY (2020)
Osteocrin attenuates inflammation, oxidative stress, apoptosis, and cardiac dysfunction in doxorubicin-induced cardiotoxicity
Can Hu et al.
CLINICAL AND TRANSLATIONAL MEDICINE (2020)
Meteorin-like protein attenuates doxorubicin-induced cardiotoxicity via activating cAMP/PKA/SIRT1 pathway
Can Hu et al.
REDOX BIOLOGY (2020)
A brief overview about the physiology of fibronectin type III domain-containing 5
Xin Zhang et al.
CELLULAR SIGNALLING (2020)
Matrine attenuates oxidative stress and cardiomyocyte apoptosis in doxorubicin-induced cardiotoxicity via maintaining AMPKα/UCP2 pathway
Can Hu et al.
ACTA PHARMACEUTICA SINICA B (2019)
Aerobic Fitness and Adherence to Guideline-Recommended Minimum Physical Activity Among Ambulatory Patients With Type 2 Diabetes Mellitus
Jennifer L. Jarvie et al.
DIABETES CARE (2019)
In vitro and in vivo investigation of cardiotoxicity associated with anticancer proteasome inhibitors and their combination with anthracycline
Zuzana Pokorna et al.
CLINICAL SCIENCE (2019)
Prospective Study of Cardiac Events During Proteasome Inhibitor Therapy for Relapsed Multiple Myeloma
Robert F. Cornell et al.
JOURNAL OF CLINICAL ONCOLOGY (2019)
Musclin, A Myokine Induced by Aerobic Exercise, Retards Muscle Atrophy During Cancer Cachexia in Mice
Andrea D. Re Cecconi et al.
CANCERS (2019)
C1q-tumour necrosis factor-related protein-3 exacerbates cardiac hypertrophy in mice
Zhen-Guo Ma et al.
CARDIOVASCULAR RESEARCH (2019)
Effect of Exercise Intervention on Cardiac Function in Type 2 Diabetes Mellitus: A Systematic Review
Maxim Verboven et al.
SPORTS MEDICINE (2019)
Landscape of heart proteome changes in a diet-induced obesity model
Danielle F. Vileigas et al.
SCIENTIFIC REPORTS (2019)
Rosmarinic acid alleviates cardiomyocyte apoptosis via cardiac fibroblast in doxorubicin-induced cardiotoxicity
Xin Zhang et al.
INTERNATIONAL JOURNAL OF BIOLOGICAL SCIENCES (2019)
T-bet deficiency attenuates cardiac remodelling in rats
Zhen-Guo Ma et al.
BASIC RESEARCH IN CARDIOLOGY (2018)
TAX1BP1 overexpression attenuates cardiac dysfunction and remodeling in STZ-induced diabetic cardiomyopathy in mice by regulating autophagy
Yang Xiao et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE (2018)
A New Secretory Peptide of Natriuretic Peptide Family, Osteocrin, Suppresses the Progression of Congestive Heart Failure After Myocardial Infarction
Takahiro Miyazaki et al.
CIRCULATION RESEARCH (2018)
Diabetes-Induced Cardiomyocyte Passive Stiffening Is Caused by Impaired Insulin-Dependent Titin Modification and Can Be Modulated by Neuregulin-1
Anna-Eliane Hopf et al.
CIRCULATION RESEARCH (2018)
Brown adipose tissue thermogenic adaptation requires Nrf1-mediated proteasomal activity
Alexander Bartelt et al.
NATURE MEDICINE (2018)
Rosmarinic acid attenuates cardiac fibrosis following long-term pressure overload via AMPKα/Smad3 signaling
Xin Zhang et al.
CELL DEATH & DISEASE (2018)
Fibroblast growth factor-21 prevents diabetic cardiomyopathy via AMPK-mediated antioxidation and lipid-lowering effects in the heart
Hong Yang et al.
CELL DEATH & DISEASE (2018)
Regulation of proteasome assembly and activity in health and disease
Adrien Rousseau et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2018)
Myonectin Is an Exercise-Induced Myokine That Protects the Heart From Ischemia-Reperfusion Injury
Naoya Otaka et al.
CIRCULATION RESEARCH (2018)
Inadequate ubiquitination-proteasome coupling contributes to myocardial ischemia-reperfusion injury
Chengjun Hu et al.
JOURNAL OF CLINICAL INVESTIGATION (2018)
C1q-TNF-Related Protein-9 Promotes Cardiac Hypertrophy and Failure
Mahesh Appari et al.
CIRCULATION RESEARCH (2017)
Examining a role for PKG Iα oxidation in the pathogenesis of cardiovascular dysfunction during diet-induced obesity
Olena Rudyk et al.
FREE RADICAL BIOLOGY AND MEDICINE (2017)
Circulating osteocrin stimulates bone growth by limiting C-type natriuretic peptide clearance
Yugo Kanai et al.
JOURNAL OF CLINICAL INVESTIGATION (2017)
Cardiac proteasome functional insufficiency plays a pathogenic role in diabetic cardiomyopathy
Jie Li et al.
JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY (2017)
Proteostasis in cardiac health and disease
Robert H. Henning et al.
NATURE REVIEWS CARDIOLOGY (2017)
Piperine Attenuates Pathological Cardiac Fibrosis Via PPAR-γ/AKT Pathways
Zhen-Guo Ma et al.
EBIOMEDICINE (2017)
Exercise Training Improves but Does Not Normalize Left Ventricular Systolic and Diastolic Function in Adolescents With Type 1 Diabetes
Silmara Gusso et al.
DIABETES CARE (2017)
FGF21 ameliorates diabetic cardiomyopathy by activating the AMPK-paraoxonase 1 signaling axis in mice
Fan Wu et al.
CLINICAL SCIENCE (2017)
CTRP3 attenuates cardiac dysfunction, inflammation, oxidative stress and cell death in diabetic cardiomyopathy in rats
Zhen-Guo Ma et al.
DIABETOLOGIA (2017)
Glucolipotoxicity diminishes cardiomyocyte TFEB and inhibits lysosomal autophagy during obesity and diabetes
Purvi C. Trivedi et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR AND CELL BIOLOGY OF LIPIDS (2016)
Mnk1 (Mitogen-Activated Protein Kinase-Interacting Kinase 1) Deficiency Aggravates Cardiac Remodeling in Mice
Yuan Yuan et al.
HYPERTENSION (2016)
Inhibition of chymotryptic-like standard proteasome activity exacerbates doxorubicin-induced cytotoxicity in primary cardiomyocytes
Eva-Margarete Spur et al.
TOXICOLOGY (2016)
How Exercise May Amend Metabolic Disturbances in Diabetic Cardiomyopathy
Anne D. Hafstad et al.
ANTIOXIDANTS & REDOX SIGNALING (2015)
Upregulation of MG53 Induces Diabetic Cardiomyopathy Through Transcriptional Activation of Peroxisome Proliferation-Activated Receptor α
Fenghua Liu et al.
CIRCULATION (2015)
Risk of hospitalization for heart failure in patients with type 2 diabetes newly treated with DPP-4 inhibitors or other oral glucose-lowering medications: a retrospective registry study on 127,555 patients from the Nationwide OsMed Health-DB Database
Gian Paolo Fadini et al.
EUROPEAN HEART JOURNAL (2015)
Musclin is an activity-stimulated myokine that enhances physical endurance
Ekaterina Subbotina et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2015)
Cardiac myocyte-secreted cAMP exerts paracrine action via adenosine receptor activation
Yassine Sassi et al.
JOURNAL OF CLINICAL INVESTIGATION (2014)
Cardiovascular Phenotype in HFpEF Patients With or Without Diabetes A RELAX Trial Ancillary Study
Brian R. Lindman et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2014)
Therapeutic effect of MG-132 on diabetic cardiomyopathy is associated with its suppression of proteasomal activities: roles of Nrf2 and NF-κB
Yuehui Wang et al.
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY (2013)
C1q/Tumor Necrosis Factor-Related Protein-9, a Novel Adipocyte-Derived Cytokine, Attenuates Adverse Remodeling in the Ischemic Mouse Heart via Protein Kinase A Activation
Yang Sun et al.
CIRCULATION (2013)
Protein Kinase G Positively Regulates Proteasome-Mediated Degradation of Misfolded Proteins
Mark J. Ranek et al.
CIRCULATION (2013)
Sildenafil and Diastolic Dysfunction After Acute Myocardial Infarction in Patients With Preserved Ejection Fraction The Sildenafil and Diastolic Dysfunction After Acute Myocardial Infarction (SIDAMI) Trial
Mads J. Andersen et al.
CIRCULATION (2013)
Chronic Inhibition of cGMP Phosphodiesterase 5A Improves Diabetic Cardiomyopathy A Randomized, Controlled Clinical Trial Using Magnetic Resonance Imaging With Myocardial Tagging
Elisa Giannetta et al.
CIRCULATION (2012)
Genetically Induced Moderate Inhibition of the Proteasome in Cardiomyocytes Exacerbates Myocardial Ischemia-Reperfusion Injury in Mice
Zongwen Tian et al.
CIRCULATION RESEARCH (2012)
Hyperamylinemia Contributes to Cardiac Dysfunction in Obesity and Diabetes A Study in Humans and Rats
Sanda Despa et al.
CIRCULATION RESEARCH (2012)
Stem Cell Antigen 1 Protects Against Cardiac Hypertrophy and Fibrosis After Pressure Overload
Heng Zhou et al.
HYPERTENSION (2012)
Severe Acute Respiratory Syndrome Coronavirus Replication Is Severely Impaired by MG132 due to Proteasome-Independent Inhibition of M-Calpain
Martha Schneider et al.
JOURNAL OF VIROLOGY (2012)
Nonproteasomal Targets of the Proteasome Inhibitors Bortezomib and Carfilzomib: a Link to Clinical Adverse Events
Shirin Arastu-Kapur et al.
CLINICAL CANCER RESEARCH (2011)
Tissue advanced glycation end products are associated with diastolic function and aerobic exercise capacity in diabetic heart failure patients
Suzan Willemsen et al.
EUROPEAN JOURNAL OF HEART FAILURE (2011)
Enhancement of proteasomal function protects against cardiac proteinopathy and ischemia/reperfusion injury in mice
Jie Li et al.
JOURNAL OF CLINICAL INVESTIGATION (2011)
Proteasome functional insufficiency activates the calcineurin-NFAT pathway in cardiomyocytes and promotes maladaptive remodelling of stressed mouse hearts
Mingxin Tang et al.
CARDIOVASCULAR RESEARCH (2010)
Ubiquitin Proteasome Dysfunction in Human Hypertrophic and Dilated Cardiomyopathies
Jaime M. Predmore et al.
CIRCULATION (2010)
A randomized trial of the impact of strict glycaemic control on myocardial diastolic function and perfusion reserve: a report from the DADD (Diabetes metlitus And Diastolic Dysfunction) study
Christina Jarnert et al.
EUROPEAN JOURNAL OF HEART FAILURE (2009)
Cardiac Muscle Protein Catabolism in Diabetes Mellitus: Activation of the Ubiquitin-Proteasome System by Insulin Deficiency
Junping Hu et al.
ENDOCRINOLOGY (2008)
Upregulation of myocardial 11 S-activated proteasome in experimental hyperglycemia
Saul R. Powell et al.
JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY (2008)
Foxol represses expression of musclin, a skeletal muscle-derived secretory factor
Atsutaka Yasui et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2007)
Impact of physical activity on cardiovascular risk factors in children with type 1 diabetes - A multicenter study of 23,251 patients
Antje Herbst et al.
DIABETES CARE (2007)
Paradoxical increase in ventricular torsion and systolic torsion rate in type I diabetic patients under tight glycemic control
J Chung et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2006)
The association between glucose abnormalities and heart failure in the population-based Reykjavik study
IS Thrainsdottir et al.
DIABETES CARE (2005)
Chronic inhibition of cyclic GMP phosphodiesterase 5A prevents and reverses cardiac hypertrophy
E Takimoto et al.
NATURE MEDICINE (2005)
Musclin, a novel skeletal muscle-derived secretory factor
H Nishizawa et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
Intrinsic muscle atrophy and toe deformity in the diabetic neuropathic foot - a magnetic resonance imaging study
SA Bus et al.
DIABETES CARE (2002)
Outcome after abnormal exercise echocardiography for patients with good exercise capacity - Prognostic importance of the extent and severity of exercise-related left ventricular dysfunction
RB McCully et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2002)
Share Paper
